PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2002. Start Trial.
Date Value
November 13, 2026 5.556
November 12, 2026 5.547
November 11, 2026 5.549
November 10, 2026 5.651
November 09, 2026 5.666
November 06, 2026 5.626
November 05, 2026 5.605
November 04, 2026 5.711
November 03, 2026 5.513
November 02, 2026 5.591
October 30, 2026 5.566
October 29, 2026 5.576
October 28, 2026 5.402
October 27, 2026 5.430
October 26, 2026 5.324
October 23, 2026 5.231
October 22, 2026 5.409
October 21, 2026 5.328
October 20, 2026 5.318
October 19, 2026 5.199
October 16, 2026 5.214
October 15, 2026 5.205
October 14, 2026 5.084
October 13, 2026 4.929
October 12, 2026 4.979
Date Value
October 09, 2026 4.976
October 08, 2026 4.954
October 07, 2026 4.960
October 06, 2026 4.873
October 05, 2026 4.878
October 02, 2026 4.881
October 01, 2026 4.882
September 30, 2026 4.935
September 29, 2026 5.118
September 28, 2026 5.160
September 25, 2026 5.110
September 24, 2026 5.043
September 23, 2026 5.013
September 22, 2026 4.963
September 21, 2026 4.952
September 18, 2026 4.931
September 17, 2026 4.950
September 16, 2026 4.872
September 15, 2026 4.869
September 14, 2026 4.882
September 11, 2026 4.818
September 10, 2026 4.829
September 09, 2026 4.829
September 08, 2026 4.837
September 04, 2026 5.62

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Roche Holding AG 5.055
AstraZeneca PLC 9.522
GSK Plc 2.285
Johnson & Johnson 7.027
Eli Lilly & Co. 15.14

PS Ratio Related Metrics